Efsubaglutide Alfa
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
Shanghai Yinnuo Pharmaceutical Technology Co · Phase 1 · Recruiting · Enrollment 36
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Efsubaglutide Alfa 5 mg QW | n/r | n/r | n/r | n/r | n/r |
| Efsubaglutide Alfa 10 mg QW | n/r | n/r | n/r | n/r | n/r |
| Efsubaglutide Alfa 20 mg QW | n/r | n/r | n/r | n/r | n/r |
| Efsubaglutide Alfa placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.